JCO Early Release, published online ahead of print Oct 22 2007
Journal of Clinical Oncology, 10.1200/JCO.2007.12.3141
Received April 24, 2007
Accepted August 21, 2007
Increasing Use of Contralateral Prophylactic Mastectomy for Breast Cancer Patients: A Trend Toward More Aggressive Surgical Treatment
Todd M. Tuttle,* Elizabeth B. Habermann, Erin H. Grund, Todd J. Morris, and Beth A. Virnig
From the Department of Surgery, Division of Surgical Oncology; Division of Health Policy and Management, University of Minnesota School of Public Health; and the University of Minnesota Medical School, Minneapolis, MN.
* To whom correspondence should be addressed. E-mail: tuttl006{at}umn.edu
Purpose: Many patients with unilateral breast cancer choose contralateral prophylactic mastectomy to prevent cancer in the opposite breast. The purpose of our study was to determine the use and trends of contralateral prophylactic mastectomy in the United States.
Patients and Methods: We used the Surveillance, Epidemiology and End Results database to review the treatment of patients with unilateral breast cancer diagnosed from 1998 through 2003. We determined the rate of contralateral prophylactic mastectomy as a proportion of all surgically treated patients and as a proportion of all mastectomies.
Results: We identified 152,755 patients with stage I, II, or III breast cancer; 4,969 patients chose contralateral prophylactic mastectomy. The rate was 3.3% for all surgically treated patients; 7.7%, for patients undergoing mastectomy. The overall rate significantly increased from 1.8% in 1998 to 4.5% in 2003. Likewise, the contralateral prophylactic mastectomy rate for patients undergoing mastectomy significantly increased from 4.2% in 1998 to 11.0% in 2003. These increased rates applied to all cancer stages and continued to the end of our study period. Young patient age, non-Hispanic white race, lobular histology, and previous cancer diagnosis were associated with significantly higher rates. Large tumor size was associated with a higher overall rate, but with a lower rate for patients undergoing mastectomy.
Conclusion: The use of contralateral prophylactic mastectomy in the United States more than doubled within the recent 6-year period of our study. Prospective studies are needed to understand the decision-making processes that have led to more aggressive breast cancer surgery.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
Related Correspondence
- Contralateral Prophylactic Mastectomy: Mind the Genetics
Evangelos Briasoulis and Dimitrios H. Roukos
JCO 2008 26: 1909-1910
[Full Text]
This article has been cited by other articles:
|
|
|
|
 
M. M. Mohiuddin and W. F. Regine
Consenting the Patient With Early-Stage Breast Cancer: "Informed" Only After Multi-Discliplinary Evaluation
J. Clin. Oncol.,
October 20, 2009;
27(30):
e158 - e159.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Morrow, R. Jagsi, A. K. Alderman, J. J. Griggs, S. T. Hawley, A. S. Hamilton, J. J. Graff, and S. J. Katz
Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer
JAMA,
October 14, 2009;
302(14):
1551 - 1556.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Katipamula, A. C. Degnim, T. Hoskin, J. C. Boughey, C. Loprinzi, C. S. Grant, K. R. Brandt, S. Pruthi, C. G. Chute, J. E. Olson, et al.
Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging
J. Clin. Oncol.,
September 1, 2009;
27(25):
4082 - 4088.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Morrow and J. R. Harris
More Mastectomies: Is This What Patients Really Want?
J. Clin. Oncol.,
September 1, 2009;
27(25):
4038 - 4040.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Tuttle, S. Jarosek, E. B. Habermann, A. Arrington, A. Abraham, T. J. Morris, and B. A. Virnig
Increasing Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma In Situ
J. Clin. Oncol.,
March 20, 2009;
27(9):
1362 - 1367.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Recht
Contralateral Prophylactic Mastectomy: Caveat Emptor
J. Clin. Oncol.,
March 20, 2009;
27(9):
1347 - 1349.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. Roukos, E. Lykoudis, and T. Liakakos
Genomics and Challenges Toward Personalized Breast Cancer Local Control
J. Clin. Oncol.,
September 10, 2008;
26(26):
4360 - 4361.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Briasoulis and D. H. Roukos
Contralateral Prophylactic Mastectomy: Mind the Genetics
J. Clin. Oncol.,
April 10, 2008;
26(11):
1909 - 1910.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Tuttle, E. B. Habermann, and B. A. Virnig
In Reply
J. Clin. Oncol.,
April 10, 2008;
26(11):
1910 - 1910.
[Full Text]
[PDF]
|
|
|
|
|
|
|
More Breast Cancer Patients Choosing Contralateral Prophylactic Mastectomy
Journal Watch Women's Health,
December 6, 2007;
2007(1206):
2 - 2.
[Full Text]
|
|
|
|
